Kyorin Pharmaceutical Co Ltd: Impact on Consolidated Earnings Forecast for Fiscal Year Ending March 2026 Is Expected to Include Upfront Payment to Hinge Bio Under This Agreement, Which Will Be Recorded as SG&a Expenses (R&D Expenses) for Current Fiscal Year
Kyorin Pharmaceutical Co Ltd: Kyorin and Hinge Bio Enter Into a Collaboration and License Agreement of Hb2198 in Japan for Sle and Other Diseases
Brazil's Dasa: Sells Mantris and Medical Diagnostics Operation in Argentina for704.8 Mln Reais - Filing
Logan: Resilient Consumption and Business Investment, Also Signs Policy Only Modestly Restrictive
Logan: Financial Conditions Are a Tailwind NOW, Evidence Policy Is Only Modestly Restrictive
Logan: Cannot Take Anchored Inflation Expectations for Granted
Logan: Even Excluding Tariff Impacts Inflation May Be as High as 2.4%, Driven by Non-Housing Services
Logan: Will Be Cautious in Any Further Reductions
Logan: Not Clear How Much Further Fed Can Cut Before Hitting Neutral
Dallas Fed's Logan: U.S. May Need Further Labor Market Slack to Reach Inflation Target of 2%
Lundin Mining Announces Updated Share Capital and Provides Update on Share Buybacks
U.S. Senate Rejects Republican Government Funding BILL, Shutdown Could Come in Hours
Republican BILL to Avert U.S. Government Shutdown Failing to Win Enough Votes to Pass in Senate; Voting Continues
Mitsubishi Heavy Industries Ltd: Jip Expected to Purchase All Our Stake in Mitsubishi Logisnext Shares for Total of About 74 Bln Yen
Mitsubishi Heavy Industries Ltd: Notice Regarding Execution of a Contract to Take Company's Consolidated Subsidiary Mitsubishi Logisnext Co., Ltd. Private